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Retinoic acid accelerates downregulation of the
Xist repressor, Oct4, and increases the likelihood
of Xist activation when Tsix is deficient
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Abstract
Background: Imbalances in X-linked gene dosage between the sexes are resolved by transcriptionally silencing
one of two X-chromosomes in female cells of the early mammalian embryo. X-inactivation is triggered by
expression of the non-coding Xist gene. In turn, Xist is dually regulated by the antisense Tsix RNA and by the Oct4
pluripotency factor. Although there is general agreement that Tsix is an inhibitor of Xist, some laboratories have
observed ectopic Xist induction in differentiating male ES cells when Tsix is mutated, whereas we have not
observed significant changes in Xist. These observational differences have led to fundamentally diverse models of
X-chromosome counting. Here, we investigate if different methods of cell differentiation and use of all -trans
retinoic acid (RA) could be causative factors and how they might impact Xist expression.
Results: We compared suspension and cell-adhesion cultures in the presence or absence of RA and find that RA
significantly impacts Xist expression in Tsix-mutant male cells. Whereas the standard embryoid body method
infrequently leads to ectopic Xist expression, adding RA generates a significant number of Xist-positive male cells.
However, while normal Xist clouds in wild-type female cells are robust and well-circumscribed, those found in the
RA-treated mutant males are loosely dispersed. Furthermore, ectopic Xist expression does not generally lead to
complete gene silencing. We attribute the effect of RA on Xist to RA’s repressive influence on Oct4, a pluripotency
factor recently shown to regulate Tsix and Xist. RA-treated ES cells exhibit accelerated decreases in Oct4 RNA levels
and also display accelerated loss of binding to Xist intron 1. When Tsix is deficient, the faster kinetics of Oct4 loss
tip the equilibrium towards Xist expression. However, the aberrant Xist clusters are unlikely to explain elevated cell
death, as X-linked silencing does not necessarily correlate with the qualitatively aberrant Xist clusters.
Conclusions: We conclude that RA treatment leads to premature downregulation of Oct4 and partial derepression
of Xist irrespective of X-chromosome counting. RA-induced Xist clusters in male cells do not result in global or
stable silencing, and excess cell death is not observed. These data and RA’s known pleiotropic effects on ES
transcription networks suggest that RA differentation bypasses normal X-inactivation controls and should be used
judiciously. We propose that the likelihood of Xist expression is determined by a balance of multiple Xist activators
and repressors, and that levels of Oct4 and Tsix are crucial toward achieving this balance.
Background
Sex dosage compensation ensures equal X-linked gene
expression between XX and XY individuals. In mam-
mals, this balance is achieved by transcriptionally silen-
cing an entire X-chromosome in females through a
process called X-chromosome inactivation (XCI) [1].
XCI is accomplished independently in each cell primar-
ily by the Xist/Tsix pair of sense/antisense non-coding
RNAs located within the X-inactivation center (Xic)
[2-5]. Xist upregulation and cis-coating of an X-chromo-
some represent important steps in the X-inactivation
process [6,7], and are followed by recruitment of the
PRC2 complex [8-10] and other silencing factors to
initiate chromosome-wide inactivation and compaction
into heterochromatin. Because X-inactivation occurs
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els have been developed to facilitate analysis. Female
mouse embryonic stem (ES) cells can undergo random
X-inactivation when differentiated in vitro [2] and have
therefore served as a powerful system with which to
study this phenomenon. Xist expression remains low on
both Xs in undifferentiated ES cells, but upon differen-
tiation, Xist becomes upregulated only on the future
inactive X [11,12]. Xist thus serves as the trigger for the
silencing step during the X-inactivation program.
Xist’s central nature to XCI has led to intensive inves-
tigation of how this gene is regulated. One established
regulator is Tsix, the antisense repressor of Xist [13,14].
Tsix RNA is expressed from both Xs in undifferentiated
female cells, but its expression becomes monoallelic
during the process of cell differentiation and XCI. The
chromosome that transiently retains Tsix expression
becomes the future active X (Xa), while the chromo-
some that extinguishes Tsix expression first becomes
the future inactive X (Xi). Tsix has been proposed to
regulate X-chromosome pairing, counting, and the
mutually exclusive choice of Xa and Xi [15-17]. Indeed,
various knockouts of Tsix (and its upstream enhancer
Xite [18]) have led to nonrandom XCI as well as effects
on counting and pairing [13-16].
Although Tsix’s repressive role in female cells seems
clear, there has been debate over Tsix’sr o l ei nm a l e
cells. The original 3.7 kb deletion encompassing the
major Tsix promoter in male ES cells (Tsix
ΔCpG/Y [13])
did not cause a significant degree of ectopic Xist upre-
gulation upon differentiation (<1%). Tsix
ΔCpG/Y ES cells
were phenotypically normal and capable of generating
chimeric mice with germline transmission, and male off-
spring were born at expected frequencies [13]. This
finding led to the conclusion that, whereas Tsix
represses Xist, an additional factor - missing in male ES
cells and present only in female cells - is required to
induce Xist expression in cells with supernumerary
X-chromosomes. It was therefore proposed that X-chro-
mosome counting involves two factors: a ‘blocking
factor’ that blocks Xist expression through Tsix on the Xa,
and a ‘competence factor’ that induces Xist expression on
Xi [13].
Significantly, however, other Tsix mutations show
variable phenotypes in male cells (Fig. 1). Sado et al.
also showed that Tsix+/- female mice can yield viable
male offspring carrying the mutation, but 8-21% of cells
isolated from E7.5 male embryos showed ectopic Xist
expression, an observation that could be explained by
either ectopic Xist expression in the embryo proper or
by presence of extraembryonic tissue (which is subject
to imprinted XCI and therefore be severely affected by
the maternal Tsix deletion) [14]. Another Tsix-specific
mutation showed upregulation of Xist RNA in as many
as 38% of differentiating male ES cells in culture [19,20].
A 65 kb deletion of the region 3′ to Xist (including Tsix)
also resulted in significant induction of Xist RNA clouds
when XO (XLD [21]) or XY (CK35Δ65 [22]) cells
underwent differentiation. Furthermore, smaller muta-
tions including only Tsix elements were also found to
have ectopic Xist cloud formation in a subset of differ-
entiating male cells (CK35Δ34 and CK35ΔAV [19]).
These observations have led to the alternative hypoth-
esis that Xist is activated by default when Tsix is
mutated, obviating the need for a competence factor
involved in female-specific expression of Xist.D i f f e r -
ences with regard to Xist expression in Tsix-deficient
male cells (hereafter referred to as X
Δ/Y ES cells) have
therefore led to fundamentally different models for
X-chromosome counting [3,13,15,22,23].
Here, we seek to understand why analyses of male
cells in different laboratories should lead to differing
results. Although the nature of the mutations could lead
to disparate results, another potential difference among
the studies might be the method of cell differentiation
used to induce XCI. Whereas we differentiate ES cells
by the embryoid body method (EB) in the absence of
LIF, many laboratories also add retinoic acid (RA) to the
differentiation medium. Although some studies have
used both the EB and EB+RA methods and found ecto-
pic Xist RNA in both cases [22,24], it remains formally
possible that the combination of induction methods,
culture conditions, and nature of the mutations could
affect the Xist phenotype.
The idea that RA affects Xist expression finds sup-
port in two recent studies thatd e m o n s t r a t e dar o l ef o r
Oct4 in repressing Xist by direct and indirect means
[25,26]. One study showed that Oct4 positively regu-
lates Tsix and that downregulation of Oct4 during cell
differentiation triggers X-chromosome pairing, leads to
monoallelic repression of Tsix, and consequently
enables Xist upregulation on one chromosome [26].
The other study showed that Oct4 also associates with
intron 1 of the Xist gene and proposed that Oct4
directly represses Xist [25]. Combined, these studies
suggest that Xist is linked to cell differentiation
through Oct4′se f f e c t so nTsix and Xist. Because it is
known that Oct4 is rapidly downregulated in the pre-
sence of retinoic acid [27-30] (by binding the regula-
tory nuclear hormone receptors, RAR and RXR [31]),
we consider the possibility that RA treatment to
induce cell differentiation may have unanticipated
effects on XCI and thereby confound XCI analysis.
Here, we set out to test the idea that RA may affect
Xist levels through Oct4 by studying one well-charac-
terized Tsix mutation, Tsix
ΔCpG, in male ES cells. Our
results indicate that differentiation methods indeed
influence Xist expression in these ES cells.
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Ectopic Xist upregulation in Tsix
ΔCpG male ES cells
differentiated in the presence of retinoic acid
We differentiated wild-type and Tsix
ΔCpG male and
female ES cells using variations of four published
in vitro differentiation techniques: (1) embryoid body
formation (EB method), whereby ES cell clusters are cul-
tured in suspension for 4 days, in the absence of LIF,
and then plated onto a solid matrix to form EB out-
growths; (2) EB method in the presence of 100 nM of
all-trans retinoic acid (EB+RA method); (3) adherent
cultures whereby ES cells are plated at low-density on
gelatinized tissue culture plates without feeders and LIF
(TC method); and (4) TC method in the presence of
100 nM all-trans retinoic acid (TC+RA method).
By Xist RNA FISH (fluorescence in situ hybridization),
we detected a slight increase in the percentage of cells
with Xist clouds using the embryoid body (EB) versus the
low-density cell adhesion (TC) method (Fig. 2A, 32% in
X/X EB compared to 18% in X/X TC at day 6). Consis-
tent with previous analysis [13], Xist clouds were rare in
X
Δ/Y cells in the absence of RA (<2-5%, n>200 cells) and
were never observed in wild-type male cells under any
differentiation condition and time point examined.
However, while no significant differences were seen
for most cell lines between EB and EB+RA or between
TC and TC+RA methods, we did detect differences for
X
Δ/Y cells (Fig. 2A,B). The differences were significant
for all differentiation days (bracketed pairwise compari-
sons, P < 0.05). Ectopic Xist RNA clusters could be seen
in 10-30% of X
Δ/Y cells (n > 200) when induced to dif-
ferentiate with RA. The ectopic Xist clouds were almost
always more dispersed than wild-type Xist clouds, which
are generally intense, compact, and well-defined (Fig.
2B, lower panels). This observation suggested a problem
with either full Xist induction or transcript localization
in mutant cells when differentiated with RA. We refer
to these abnormal clouds as ‘dispersed clusters’ to
emphasize these qualitative differences from wild-type
Xist RNA clouds. X- and Y-chromosome DNA FISH
confirmed that all ES cell lines used in this study exhib-
ited the correct XX or XY constitution (Fig. 2C).
We conclude that the method of cell differentiation
can impact Xist expression in X
Δ/Y ES cells. Specifically,
differentiation in the presence of RA leads to the
appearance of ectopic Xist clusters only when Tsix is
deleted and, when they do appear, the RNA is loosely
clustered.
RA induction accelerates loss of Oct4 binding to Xist
Recent studies suggest that Xist is negatively regulated
not only by Tsix but also by Oct4 [25,26]. Because RA
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Figure 1 Summary of Xist phenotypes in Tsix-mutant male ES cell lines. All mutant ES cell lines are XY diploid male (except where noted)
and listed with the names used in the original references. XY Tg, male transgenic line; shaded rectangle represents the 37-kb region re-inserted
into a deleted locus; ￿￿￿, extends beyond the Xic diagram depicted; RA, retinoic acid. SA/tpA, please refer to cited references for details. The ‘yes/
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Figure 2 Ectopic Xist RNA clouds observed in Tsix-mutant male ES cells. A. Percentage of cells containing Xist RNA clouds. Note the high
percentage of Xist-positive cells in X
Δ/Y cells when differentiated in the presence of RA. Days of differentiation are listed as day 2 (d2), day 4
(d4), and day 6 (d6). Day 6 X
Δ/X EB+RA, not determined (n.d.). X/Y, wild-type male ES line; X/X, wild-type female ES line; X
Δ/Y, Tsix
ΔCpG/Y male ES
line; X
Δ/X, Tsix
ΔCpG/+ female ES line; n > 200 for each timepoint and cell line examined. Error bars represent the standard deviation from three
independent biological replicates. P was calculated by paired, two-tailed Student’s t-tests. Differences in the number of Xist
+ cells for RA-free
versus RA-induced X
Δ/Y cells were statistically significant on all differentiation days (each red asterisk denotes P < 0.05 for day 2, day 4, and day
6 comparisons). EB, EB+RA, TC, and TC+RA conditions are described in the Materials and Methods. B. Xist RNA FISH showing ectopic and diffuse
Xist cluster formation (arrows) in differentiating Tsix
ΔCpG male cells. Arrows denote Xist RNA clusters. The RNA FISH probe is double-stranded.
Pinpoint signals primarily detect mildly elevated Xist expression in mutant cells caused by the Tsix deficiency, though ~10% residual Tsix
expression from an upstream promoter may also contribute [13]. Below is a side-by-side comparison at day 6 (in grayscale) of a normal compact
Xist RNA cloud (X/X, left) next to the ectopic dispersed Xist cluster observed in X
Δ/Y cells (right). C. X- and Y-chromosome paint confirm that all
ES cell lines carry the appropriate number of sex chromosomes. Red, X-chromosome; green, Y-chromosome.
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Page 4 of 14has been shown to negatively regulate the murine Oct4
promoter during ES cell differentiation [27-30], we
asked if increased Xist expression might be due to accel-
erated Oct4 loss; i.e., in the absence of the second regu-
latory arm (Tsix), RA-treated cells would ectopically
express Xist. By real-time RT-PCR, we compared rela-
tive Xist and Oct4 expression levels in differentiating
male ES cells using the four described differentiation
methods. In wild-type male cells, Xist was rapidly down-
regulated upon cell differentiation in a manner that cor-
related with downregulation of Oct4. In X
Δ/Y cells
differentiated by the EB method, Xist RNA was mildly
upregulated upon cell differentiation when Oct4 levels
dropped (Fig. 3), but this modest upregulation of Xist
did not result in spreading of Xist RNA along the X,
consistent with prior findings [13]. Thus, Tsix represses
Xist even in male ES cells, but its absence only modestly
increases Xist levels [13,14].
Differentiation with RA revealed two differences. First,
while wild-type male cells appropriately repressed Xist
expression, X
Δ/Y ES cells displayed a significant rise in
overall Xist RNA levels using the RA method (Fig. 3).
This is consistent with the observation that, when differ-
entiated via the EB method, <2-5% of X
Δ/Y cells showed
Xist clusters, but this percentage increased to 10-30% in
the presence of RA (Fig. 2A). Similar results were
obtained for both EB+RA and TC+RA conditions. At no
time of differentiation up to day 6, however, did Xist
levels increase by more than 2- to 10-fold in mutant
male cells. Thus, Xist upregulation is considerably
blunted in RA-induced Tsix-deficient male cells when
compared to the 30- to 100-fold induction that typically
accompanies XCI in normal female cells (data not
shown) [13,32-34]. These results showed that RA differ-
entiation led to a higher likelihood of Xist induction in
Tsix-deficient male ES cells.
Second, Oct4 downregulation generally occurred more
quickly in both wild-type and mutant male ES cells
when compared to the same cells grown in the absence
of RA (Fig. 3; see pairwise t-tests done for each cell line
comparing between EB/EB+RA (red asterisks) and TC/
TC+RA (green asterisks)). While Oct4 RNA levels were
similar in wild-type and mutant ES cells in the undiffer-
entiated state, differentiation revealed a significant dif-
ference in Oct4 mRNA levels at days 4 and/or 6
dependent on whether RA was added to the culture or
not. RA accelerated the rate of Oct4 decrease regardless
of whether the ES cells were grown as EBs (compare EB
versus EB+RA) or as adherent cells (compare TC versus
TC+RA). The greatest difference was evident when
adherent cells were used. Although Oct4 mRNA differ-
ences are small, cells at this early stage of differentiation
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Figure 3 RA-induced differentiation causes sharper decreases in Oct4 mRNA levels. Xist and Oct4 RNA levels in wild-type and Tsix-mutant
male ES cells under various differentiation conditions. Error bars represent one standard deviation from the mean. Days of differentiation are
listed as day 0 (d0), day 2 (d2), day 4 (d4), and day 6 (d6). Pairwise comparisons were made between corresponding samples at each
differentiation time point for EB vs. EB+RA (red asterisks) and TC vs. TC+RA (green asterisks). * P < 0.05. Statistical significance was calculated
using paired, two-tailed Student’s t-tests.
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Page 5 of 14may be more sensitive to subtle changes in levels since a
specific range of Oct4 concentration is required to
maintain ES cells as pluripotent stem cells [35]. We
note that the cell-adhesion method of differentiation has
also been used and shown to form ectopic Xist RNA in
Tsix-deficient male cells [19,22].
To determine whether the accelerated overall decrease
in Oct4 levels has a direct impact on Xist expression, we
asked if the kinetics of Oct4 loss at the Xist locus were
altered in RA-containing versus RA-free cultures. Oct4
was previously shown to bind Xist intron 1 in ES cells
[25]. It was proposed that Oct4 binding represses Xist in
undifferentiated cells and that the loss of Oct4 binding
during cell differentiation enables Xist upregulation. We
therefore investigated whether cell differentiation trig-
gered by RA might lead to accelerated loss of Oct4 bind-
ing to Xist intron 1 and increased Xist expression. By
performing chromatin immunoprecipitations (ChIPs)
using a-Oct4 antibodies on wild-type and Tsix-deficient
male cells differentiated in parallel, we found that indeed
Oct4-binding to Xist intron 1B was lost significantly
more quickly when cells were differentiated in the pre-
sence of RA (Fig. 4; P < 0.05, see bracketed pairwise com-
p a r i s o n s ) .W ef o u n dt h a ti n d e e dO c t 4 - b i n d i n gt oXist
intron 1B was lost significantly more quickly when cells
were differentiated in the presence of RA (Fig. 4; P <
0.05, see bracketed pairwise comparisons). Differences
were evident as early as day 2. The difference was most
evident for WT EB with versus without RA treatment;
however, we note that the difference between mutant EB
plus versus minus RA treatment might have been masked
by somewhat lower Oct4 binding by d2. As a negative
control, we looked at a region within intron 1 of Xist
(intron 1A, located 0.6 kb away from intron 1B), which is
not known to bind Oct4 [26], and found no statistically
significant differences between EB and EB+RA methods.
Thus, RA treatment leads to a more rapid loss of Oct4
binding to Xist intron 1 than is typically seen when ES
cells are differentiated without RA.
Taken together, these data indicated that RA treat-
ment has little effect on Xist RNA upregulation when
Tsix is present, but increases the likelihood with which
Xist will be induced when Tsix is deficient. We propose
that RA’s effect in the absence of Tsix is related to the
rapid downregulation of Oct4 by RA, which in turn
leads to accelerated loss of Oct4 binding to Xist intron
1. We suggest that, when these events occur in a Tsix-
deficient background, Xist is more likely to become
derepressed. Overall Oct4 levels are also downregulated
in wildtype cells when treated with RA, but the persis-
tence of Tsix would antagonize the derepressive forces.
These findings are consistent with the idea that Oct4
and Tsix act in parallel to regulate Xist expression
[25,26].
X-chromosome silencing in mutant cells with dispersed
Xist clusters
We next addressed whether the 2- to 10-fold increases
in Xist levels and formation of dispersed Xist RNA clus-
ters led to X-chromosome silencing in RA-treated Tsix-
mutant cells. First, to correlate Xist expression with
gene silencing on a cell-by-cell basis, we carried out
RNA FISH using probes to simultaneously detect Xist
and nascent transcription from the X-linked Pgk1 locus.
In wild-type X/X cells that have undergone XCI, nascent
Pgk1 RNA signals are generally not observed on the Xi,
whereas they can be observed in ~60% on the Xa at a
g i v e nt i m ep o i n t[ 1 3 ]( F i g .5 Aa n dd a t an o ts h o w n ) .W e
reasoned that, if ectopic Xist clusters led to gene silen-
cing in X
Δ/Y cells, Pgk1 RNA would not be detectable
on the Xist-coated X
Δ. On the other hand, if the aber-
rant Xist clusters could not silence genes in cis,6 0 %o f
X
Δ would continue to express Pgk1. When differentiated
using the RA method, 30% (21/70) of X
Δ/Y cells with
Xist accumulation showed nascent Pgk1 signals (Fig.
5A), suggesting that complete silencing did not always
follow Xist accumulation at this time point, though a
fraction of EB+RA cells appeared to undergo inactiva-
tion. By contrast, when differentiated using the EB
method, X
Δ/Y cells did not express Xist, and Pgk1
expression was observed at the expected frequency of
~ 6 0 %( F i g .5 A ) .T h u s ,a l t h o u g hXist was partially dere-
pressed by RA treatment of X
Δ/Y cells, silencing of
genes in cis did not proceed to completion.
With respect to XCI, the X can be divided into genic
versus repetitive element fractions [36,37]. To assess
whether repetitive element silencing proceeded to com-
pletion, we carried out RNA FISH using probes from
the Cot-1 fraction [38], the genomic fraction containing
the most highly repetitive elements. In cells where XCI
is firmly established, the inactive X lies either completely
or partially within a “Cot-1 hole” (i.e., the inactive X is
depleted for repetitive element expression) [36-39]. In
wild-type EB cells on day 6 of differentiation, 22.2% of
X i s tc l o u d sl a ye n t i r e l yw i t h i naC o t - 1h o l ea n d5 8 . 7 %
were partially within a Cot-1 hole; only 19% did not
appear to overlap with a Cot-1 hole at all (Fig. 5B). By
contrast, in RA-differentiated X
Δ/Y EB, 18.8% of aber-
rant Xist RNA clusters were located within a Cot-1 hole
and 44.9% partially within a Cot-1 hole, whereas 36.3%
d i dn o to v e r l a pw i t haC o t - 1h o l ea ta l l( F i g .5 B ) .
Because the ectopic Xist RNA clusters in X
Δ/Y cells
were very diffuse, Xist RNA could often be found in
Cot-1
+ regions (and were scored as ‘partially within a
Cot-1 hole’). Interestingly though, Xist RNA clusters
scored as ‘entirely within a Cot-1 hole’ appeared more
compact, suggesting that perhaps only those cells were
able to sufficiently silence their X-chromosomes. Taken
together, these results demonstrated that a significant
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Page 6 of 14fraction of RA-treated mutant male cells had not com-
pleted repeat silencing, suggesting either a delay or a
failure to do so. Thus, both genic and repeat silencing
were at least partially compromised in X
Δ/Y cells with
ectopic and diffuse Xist expression induced by RA-
mediated cell differentiation.
Next we reasoned that, if Xist induction by RA led to
XCI in part, differentiating X
Δ/Y cells would show cell
death in excess of wild-type cells. However, an equiva-
lent level of cell death was observed for mutant and
wild-type cells, suggesting that the X
Δ chromosome
could not have been silenced to a significant extent (Fig.
5C). Notably, regardless of the Tsix genotype, the mag-
nitude of cell death was consistently greater and the
population doubling time was substantially slower when
cells were differentiated using the RA method (Fig. 5C).
Comparison of EB versus EB+RA conditions showed
that <50% of cells - either wild-type or mutant - sur-
vived RA treatment during the first 6 days. Comparison
of TC versus TC+RA showed that addition of RA
caused a >95% drop in cell viability over the same per-
iod. These results demonstrate that the Tsix mutation
does not have a major effect on the viability of male
cells and that RA alone - irrespective of the Tsix defi-
ciency and RA’s partial effect on Xist induction - has
major effects on cell viability that are unrelated to the
XCI pathway. This effect of RA raises the possibility of
selection artifacts when mutations are analyzed in the
presence of RA.
Discussion
Here, we have shown that differentiation in the presence
of RA results in partial upregulation of Xist RNA when
Tsix is deleted in male ES cells. We believe that this
results from accelerated loss of Oct4 and that the deple-
tion of both Tsix and Oct4 (both repressors of Xist)i n
differentiating ES cells leads to ectopic Xist expression.
However, the ectopic Xist clusters appear more dis-
persed than those typically seen in wild-type female
cells, and the degree of Xist activation is an order of
magnitude lower. Consistent with these aberrant quali-
ties, the dispersed Xist clusters do not globally or stably
silence the male X-chromosome. Thus, RA-induced Xist
expression in a Tsix-deficient background does not lead
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Figure 4 Oct4-binding to Xist intron 1 decreases faster when differentiated in the presence of RA.Q u a n t i t a t i v eC h I Pa n a l y s e so fO c t 4 -
binding to Xist intron 1 show faster reductions in Oct4-binding kinetics when wild-type and Tsix-deficient male cells were differentiated by EB
+RA versus EB methods. Note that, for each experiment, we started with a single d0 (undifferentiated) culture for both X/Y and X
Δ/Y, and then
split them on subsequent days for analysis. Thus, d0 samples were the same for all EB series and for all EB+RA series, and their values were
duplicated in the graphs for easier comparisons with d2, d4, d6 samples in the same series. Means ± s.e.m from two independent biological
replicates are shown. Pairwise comparisons were made between corresponding samples (EB vs. EB+RA) normalized to the control IgG ChIP
(background) for each time point. Statistical significance of each result was calculated using paired, two-tailed Student’s t-tests. * p < 0.05.
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Figure 5 RA-containing cultures lead to silencing of the X-linked gene Pgk1 and exhibit slower overall growth than cultures without
RA. A. Xist/Pgk1 RNA FISH showing the percentage of Pgk1 expression in X
Δ/Y cells differentiated under the EB or EB+RA condition at day 6. EB
+RA percentages represent only those cells positive for dispersed Xist RNA clusters. EB percentages represent all cells expressing basal Xist levels.
B. Xist/Cot-1 RNA FISH of X/X (EB) and X
Δ/Y (EB+RA) with Xist RNA clouds at day 6. Percentages represent Xist+ cells that were scored to be
located within a Cot-1 RNA hole, partially within a Cot-1 hole, or excluded from a Cot-1 hole, as indicated. Note the higher percentage of Xist
clouds excluded from a Cot-1 hole in X
Δ/Y cells when compared to X/X cells. Arrows point to Xist clouds/clusters and their corresponding Cot-1
regions. C. Growth curves for wild-type and Tsix-mutant male cells differentiated under EB/EB+RA (left) or TC/TC+RA (right) conditions. Cultures
containing RA (denoted in shades of red) had <50% of cells than those cultures grown in the absence of RA (denoted in shades of blue). No
differences were seen between X/Y and X
Δ/Y grown under similar conditions. Error bars represent one standard deviation from the mean; days
of differentiation are listed as day 0 (d0), day 2 (d2), day 4 (d4), and day 6 (d6).
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Page 8 of 14to proper and complete XCI. We also observed that RA
treatment uniformly causes massive cell death (>50%)
regardless of the Tsix genotype. Nonetheless, the frac-
tion of Tsix-deficient male cells that do initiate silencing
may be selected against, thus enriching for cells that
have not properly initiated XCI. In view of our findings,
we suggest that RA differentiation of XCI mutants
should be analyzed carefully because RA treatment
could either create selection artifacts or indirectly affect
XCI through RA’s established pleiotropic effects.
It has long been known that RA regulates expression
of the POU-domain transcription factor Oct4 (also
referred to as Oct3/4 and Pou5f1), which is restricted to
pluripotent stem cells and is downregulated when
induced to differentiate by treatment with RA [27-30].
RA and other vitamin A derivatives have pervasive
effects on developmental processes–including vertebrate
embryogenesis, growth, differentiation, and homeosta-
sis–primarily through binding to the RAR and RXR
nuclear hormone receptors [31]. RAR isoforms mediate
transcriptional activation through binding of either 9-cis
or all-trans RA [40,41], while RXRs (a, b, g) work speci-
fically through 9-cis-RA [31,42-44]. These receptors
form homo- or heterodimeric complexes and bind RA-
responsive elements in target genes to transcriptionally
mediate expression [45-49]. Oct4 is regulated at the
level of transcription [35] through binding of RARs [50],
chick ovalbumin upstream promoter transcription fac-
tors (COUP-TFs) [51], germ cell nuclear factor (GCNF),
as well as other proteins [52], to upstream enhancer
regions (designated DE and PE for distal and proximal
enhancers, respectively) [50] and an Sp1 site [53] located
within the Oct4 promoter. Upon RA-induced differentia-
tion, these specific factors bind to and downregulate
Oct4 in ES and EC cells [50,51,54]. It is possible that
these genome-wide and pleiotropic effects of RA would
have indirect effects on XCI, which might thereby
explain differences in the Xist phenotype observed in
our Tsix-deficient background from those of others.
Xist differences in EB- versus RA-differentiated cul-
tures can be summarized by the model shown in Figure
6. Our model supposes that Xist is independently
repressed by Oct4 and Tsix. In undifferentiated wild-
type male ES cells (Fig. 6A), high levels of Oct4–along
with Nanog and Sox2–bind within intron 1 of the Xist
gene [25,26] and keep Xist expression at a “basal” level
(<10 copies per cell) [8,55,56]. Oct4 also binds to Tsix/
Xite to transactivate antisense transcription (not shown),
which in turn also represses Xist [25,26]. During differ-
entiation into EBs, Oct4 expression decreases slowly and
remains high enough during early differentiation to
maintain Xist repression. At the same time, persistent
Tsix expression stably switches off Xist (“off” state)
[33,55,57-59]. This early stage corresponds to the
reversible Xist-dependent time window for XCI [60].
Later during differentiation, Oct4 is significantly down-
regulated, Tsix is extinguished, and Xist is safely and
stably repressed, possibly by a transcriptional gene silen-
cing (TGS)-like mechanism and by DNA methylation of
the Xist promoter [59,61] (after the Xist-dependent time
window [60]). Under conditions of RA-induced differen-
tiation and accelerated loss of Oct4, the outcome would
be similar, as Tsix ensures continued repression of Xist.
In X
Δ/Y cells, the outcome would be different (Fig. 6B).
Ordinarily, the rapid drop in Oct4 levels during RA-
induced differentiation would have little impact on Xist,a s
an intact Tsix would suppress full Xist activation. How-
ever, deletion of Tsix would eliminate the second arm of
Xist regulation, resulting in ectopic Xist expression. The
increase in Xist expression would be modest, would not
yield robust Xist clouds, and would not necessarily be fol-
lowed by chromosome-wide inactivation, explaining why
we did not observe a noticeable increase in cell death.
Although we prefer this model, we cannot exclude
other potential explanations for the behavior of
Tsix
ΔCpG/Y cells in general. It is clear that the Xist pro-
moter is not properly silenced in RA-differentiated Tsix-
mutant male cells. Therefore, it is possible that a very
small minority of Tsix
ΔCpG/Y cells that initiate XCI dur-
ing the early time window (when the Xi can be estab-
lished) are selected against and are rarely observed.
Because Xist is not properly silenced in the absence of
Tsix, cells might continue to upregulate Xist at later
stages and form improper and abnormal Xist RNA clus-
ters, which would not be capable of silencing the X.
These cells might then survive longer and be observed
by our assay. Although this scenario is possible, we do
not believe that it can explain the observations related
to RA made in this study. Firstly, ectopic Xist expression
is rarely observed without RA treatment. Secondly, in
the presence of RA, Xist RNA clusters are actually
observed during the early time window during the silen-
cing-competent phase of XCI. Thus, we believe that the
more likely explanation is the one offered in Figure 6.
Interestingly, the percentage of RA-differentiated cells
with ectopic Xist upregulation in a Tsix-mutant back-
ground is similar among other studies and our own
(~10% at day 2) [19,20,22]. Our results are also consis-
tent with those reported by Navarro et al. for an Oct4-
null male ES line. Although these authors reported that
Xist upregulation was not seen in Oct4-null male ES
cells when differentiated by retinoic acid alone [25], this
line contained a tetracycline-repressible Oct4 transgene
which lacked the endogenous Oct4 promoter and
upstream enhancer regions (PE and DE). As the retinoic
acid repressible elements [50,62] are located within this
region, their Oct4-null male line would not be directly
affected by RA treatment.
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Figure 6 Model of RA-induced Xist expression in Tsix-mutant male cells. A. Undifferentiated wild-type X/Y cells maintain high levels of
Oct4, Sox2, and Nanog, which bind to Xist intron 1. This synergistic binding – in addition to high Tsix RNA expression – effectively suppresses
Xist. Under the EB differentiation method (left), Oct4 expression remains high early during differentiation, allowing continued binding of Oct4,
Sox2, and Nanog to keep Xist off. Although Oct4 levels and binding decrease during late differentiation, Xist continues to remain repressed as
the Xist-dependent phase of XCI has passed. Under the RA differentiation method (right), RA binds to its receptor to form RAR complexes,
which then bind to and negatively regulate Oct4. However, persistent Tsix expression maintains stable Xist repression. B. In undifferentiated X
Δ/Y
cells, high levels of Oct4, Sox2, and Nanog are sufficient to repress Xist in the absence of Tsix. Under the EB differentiation method (left), Oct4
expression remains high early during differentiation, allowing continued binding of Oct4, Sox2, and Nanog to maintain low Xist expression even
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to accumulate and diffusely coats the chromosome in cis, leading to formation of visible Xist RNA clusters and incomplete silencing. DE and PE
refer to distal and proximal Oct4 enhancers, respectively.
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sion is determined by a balance of multiple Xist activa-
tors and repressors, consistent with other proposed
models [13,15,23,63-65]. Deletion, mutation or down-
regulation of repressive factors would predispose that
X-chromosome to inactivation, but would ordinarily not
lead to ectopic inactivation in male cells when other
repressors are present. Thus, deletion of the Tsix locus
alone in male cells would prevent binding of XCI
repressive factors to the single X-chromosome but not
lead to ectopic inactivation. However, the absence of
Tsix in combination with premature loss of Oct4-bind-
ing to Xist intron 1 due to RA-induced differentiation in
Tsix
ΔCpG/Y male cells would be sufficient to derepress
Xist expression independently from this sensing
mechanism.
This idea may explain why some investigators have
observed the appearance of Xist clusters even when
Tsix-deficient cells were differentiated using the EB
method. In our hands, Tsix
ΔCpG/Y ES cells rarely show
Xist clusters (<5%). Sado et al. have reported that the
Tsix
pAA2Δ1.7/Y mutant shows slightly more Xist clusters
during early differentiation by the EB method (~10%)
[14,24], which may be explained by the severity of this
Tsix mutation. The Tsix
pAA2Δ1.7 mutation is a severe
truncation mutation with lethality being highly pene-
trant in the mouse [14,24], whereas the Tsix
ΔCpG muta-
tion shows ~10% residual antisense expression and
shows lower penetrance of lethality in mice [13,66]. The
combination of a severe Tsix
pAA2Δ1.7 mutation with RA-
accelerated Oct4 depletion could explain why Xist upre-
gulation is more frequently seen than in the case for our
Tsix
ΔCpG mutation. The 65 kb deletion of Avner and
colleagues yields an even greater number of Xist
+ cells
when differentiated into EBs [19,22]. Because the 65 kb
deletion includes all of the 5′ end of Tsix and Xite and
deletes two of the three known Oct4-binding sites
within the Xic [25,26], we propose that combining it
with accelerated decreases in both RA-induced Oct4
transcription and binding would further increase the
likelihood of Xist expression.
Conclusions
We argue that the moderate elevation of Xist RNA
levels in RA-treated X
Δ/Y cells is not due to aberrant X-
chromosome counting but to premature Oct4 downre-
gulation and accelerated loss of Oct4-binding to Xist
intron 1. RA also has general pleiotropic effects on tran-
scription that could further affect the XCI process. Our
observations suggest that cells lacking Tsix -w h e nd i f -
ferentiated under more physiological conditions (such as
that simulated by LIF withdrawal and formation of EBs)
- remain capable of suppressing Xist and preserving via-
bility. These ideas are consistent with the two-factor
model, which proposes that a repressive “blocking” fac-
tor and an activating “competence” factor coordinately
regulate the X-chromosome counting process [13,15].
By this model, Xist RNA is induced and XCI is initiated
only when the blocking factor is not bound in cis and a
competence factor (expressed only in X/X cells) is pre-
sent. Both X/Y and X
Δ/Y cells would lack the compe-
tence factor and be incapable of fully initiating XCI
even if Tsix and the blocking factor were eliminated.
Apart from the consequences shown here, RA’s accel-
eration of Oct4 downregulation would also be expected
to alter the timing of X-chromosome pairing, an event
proposed to regulate X-chromosome counting, and
thereby account for why different studies observe pair-
ing on different differentiation days [16,17]. Relevantly,
Oct4 has been shown to control the timing of X-chro-
mosome pairing [26]. We suggest, therefore, that RA
should be used judiciously in studies of X-chromosome
counting and other events surrounding the initiation of
XCI.
Methods
ES cell lines and culture
Wild-type male (J1), female (EL16.7), and Tsix-mutant
(CG7 male and 3F1 female) ES cell lines and culture
conditions have been previously described [13].
ES cell differentiation
Each ES cell line was differentiated for six days using
one of the following differentiation methods: (1) suspen-
sion cultures forming embryoid bodies (EB), (2) suspen-
sion cultures forming EBs + 100 nM of all-trans retinoic
acid (EB+RA), (3) cells plated at low density on 0.2%
gelatinized tissue culture plates (TC), and (4) cells plated
at low density on 0.2% gelatinized tissue culture plates +
100 nM all-trans retinoic acid (TC+RA). LIF (leukemia
inhibitory factor) was removed in all differentiation
methods. EB and EB+RA cultures had a starting concen-
tration of ~5 × 10
5 cells/60 cm
2, while TC and TC+RA
cultures had a starting concentration of ~1 × 10
5 cells/
60 cm
2. Culture medium was changed every two days,
and 100 nM all-trans retinoic acid was added fresh
where appropriate. All-trans retinoic acid (Sigma Cat #
R2625) was diluted in DMSO as 10 mM stock solutions,
stored in light-protected vials at -20°C, and diluted in
culture media just prior to use. All experiments were
performed three times. Viable cells were counted using
a Cellometer Auto cell counter (Nexcelom Biosciences).
RNA fluorescence in situ hybridization
ES cells were trypsinized into single cells, cytospun onto
glass slides, fixed in 4% paraformaldehyde/1xPBS, and
FISH was carried out as described [13]. Xist, Pgk1,a n d
Cot-1 RNA were detected using double-stranded DNA
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Page 11 of 14probes labeled with Cy3-dUTP or FITC-dUTP either by
nick-translation (Roche) or using the Prime-It Fluor
Fluorescence Labeling Kit (Stratagene). Digital images
were taken with a Nikon Eclipse 90i microscope (Nikon
Instruments, Inc.) and processed using Volocity software
(Improvision). In brief, z-sections were captured at 0.2
μm intervals, and 3-D images were projected onto a sin-
gle 2-D plane. Cells were counted and scored for the
presence or absence of an Xist cloud or cluster. X- and
Y-chromosome paint was performed on undifferentiated
cells as previously described [67] using StarFISH Cy3-
or FITC-labeled probes from Cambio.
Real-time RT-PCR
Total cellular RNA was isolated from TRIzol reagent
(Invitrogen) by phenol/chloroform extraction and trea-
ted with TURBO DNase (Ambion). RNA (1 μg) was
reverse transcribed into cDNA with random hexamers
using the SuperScript III First-Strand Synthesis System
(Invitrogen) following the manufacturer’si n s t r u c t i o n s .
Real-time PCR was performed on a Bio-Rad iCycler
machine with SYBR-Green iQ Mix (Bio-Rad). After an
initial denaturation at 95°C for 8:30 min, reactions were
amplified for 40 cycles: 95°C for 30 s, 58°C for 30 s,
72°C for 30 s, followed by dissociation curve analyses at
55°C for 1 min and 55°C + 0.5°C every 20 s. Xist pri-
mers amplified exons 1-3 of the cDNA and were as fol-
lows: NS66, 5′-GCTGGTTCGTCTATCTTGTGGG-3′
and NS33, 5′-CAGAGTAGCGAGGACTTGAAGAG-3′
[34]. Oct 4 and GAPDH primers were as follows: Oct4F,
5′-GAAGCAGAAGAGGATCACCTTG-3′;O c t 4 R ,5 ′-
TTCTTAAGGCTGAGCTGCAAG-3′;G A P D H 1 F ,5 ′-
ATGAATACGGCTACAGCAACAGG-3′;G A P D H 1 R ,
5′-CTCTTGCTCAGTGTCCTTGCTG-3′. All primers
were added at a final concentration of 200 nM. The Ct
(defined as the cycle number at which the fluorescence
exceeds the threshold value) was determined for each
reaction run in triplicate, and relative-fold differences
were calculated using the 2
-ΔΔCt method normalized to
GAPDH levels and female fibroblasts (for Xist) or
undifferentiated ES cells (for Oct4) as a reference
sample [68].
Chromatin immunoprecipitations (ChIPs)
ChIP analyses were carried out using a modified proto-
col from Millipore, and the results were averaged for
two independent biological replicates of wild-type and
Tsix
ΔCpG male cells at day 0, day 2, day 4, and day 6 of
differentiation; error bars denote standard errors of the
means.
Chromatin isolation
Briefly, 1-2 × 10
7 cells were trypsinized into a single-cell
suspension and crosslinked with formaldehyde to a final
concentration of 1% at 37°C for 10 min. Crosslinking
was quenched with glycine (125 mM final), and cells
were pelleted at 640 g for 5 min and washed twice with
1× phosphate buffered saline containing protease inhibi-
tors (Roche mini cOmplete protease inhibitor cocktail
tablets, EDTA-free #11-836-170-001). Nuclei were iso-
lated from fixed cells by washing once with Buffer A-
NP-40 (5 mM PIPES, pH 8.0, 85 mM KCl, 0.5% NP-40),
incubated on ice for 10 min, then washed with Buffer A
(5 mM PIPES, pH 8.0, 85 mM KCl) and Lysis Buffer (10
mM Tris-HCl, pH 8.0, 10 mM NaCl, 3 mM MgCl2,
0.5% NP-40). Pelleted nuclei were resuspended in
MNase buffer (10 mM Tris-HCl, pH 8.0, 10 mM NaCl,
3m MM g C l 2, 1 mM CaCl2, 4% NP-40) containing pro-
tease inhibitors and 1% SDS. Lysates were sonicated
using the Bioruptor XL (Diagenode) [15 min total with
30 s on- and 30 s off-cycles]. Sonicated lysates were cen-
trifuged at 16,100 g for 10 min, and the supernatants
were stored at -80°C.
Immunoprecipitation
All IP steps were performed at 4°C. For each immuno-
precipitation, 50 μl of Dynal Protein G-magnetic beads
(Invitrogen # 100-04D) were first incubated with 5 μgo f
appropriate antibody for 2 hours with rotation, then
with sonicated supernatants (~2.0 × 10
6 cells) overnight.
IP samples were washed twice each with Low Salt TSE
150 (20 mM Tris-HCl, pH 8.0, 0.1% SDS, 1% Triton X-
100, 2 mM EDTA, 150 mM NaCl), High Salt TSE 500
(20 mM Tris-HCl, pH 8.0, 0.1% SDS, 1% Triton X-100,
2 mM EDTA, 500 mM NaCl), LiCl Buffer (10 mM Tris-
HCl, pH 8.0, 250 mM LiCl, 1% NP-40, 1% deoxycholate,
1 mM EDTA), and TE Buffer (10 mM Tris-HCl, pH 8.0,
1 mM EDTA). Protein/antibody complexes were eluted
from the beads with freshly made Elution Buffer
(50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% SDS,
50 mM NaHCO3) incubated at 65°C for 10 min. Cross-
links were reversed by digestion with 80 μg proteinase K
at 65°C for 4 hours, and DNA was recovered by phenol/
chloroform extraction.
ChIP antibodies included goat polyclonal anti-Oct4
(Santa Cruz #sc8628) and normal rabbit IgG (Cell Sig-
naling #2729). Quantitative PCR was performed using
an iCycler iQ real-time PCR detection system (Bio-Rad)
with primers specific to Xist intron 1 (site A: p63/p64,
distanced 0.6 kb from site B: p65/p66). Primer
sequences were as follows: p63, 5′-CTGAAGATGGT-
GATGGCGAGTTG-3′; p64, 5′-AAAGAGTTCCC-
CAAATTAGTGTCCTG-3′;p 6 5 ,5 ′-ATGTTTCCTT
TTGAAGCAGTTACTTGTAC-3′; p66, 5-CATTGTCTG
GCTCTCTAGGTGATAATAC-3′ [26]. Pairwise com-
parisons were made between corresponding samples (EB
vs. EB+RA) normalized to the control IgG ChIP (back-
ground) for each time point. Statistical significance of
each result was calculated using a paired, two-tailed
t-test. * p < 0.05
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